Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Performance of Novel Molecular Point of Care Diagnostics for SARS-CoV-2

NCT06055218 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.

NCT NCT06055218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06055218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Performance of Novel Molecular Point of Care Diagnostics for SARS-CoV-2
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Phase
Observational
Overall status
Completed
Start date
January 30, 2023
Completion date
August 30, 2023
Enrollment
600 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection